Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Transitions in cell potency during early mouse development are driven by Notch.

Menchero S, Rollan I, Lopez-Izquierdo A, Andreu MJ, Sainz de Aja J, Kang M, Adan J, Benedito R, Rayon T, Hadjantonakis AK, Manzanares M.

Elife. 2019 Apr 8;8. pii: e42930. doi: 10.7554/eLife.42930.

2.

Site-Specific Antibody Drug Conjugates Using Streamlined Expressed Protein Ligation.

Frutos S, Hernández JL, Otero A, Calvis C, Adan J, Mitjans F, Vila-Perelló M.

Bioconjug Chem. 2018 Nov 21;29(11):3503-3508. doi: 10.1021/acs.bioconjchem.8b00630. Epub 2018 Oct 22.

PMID:
30346741
3.

Unraveling Gardnerella vaginalis Surface Proteins Using Cell Shaving Proteomics.

Marín E, Haesaert A, Padilla L, Adán J, Hernáez ML, Monteoliva L, Gil C.

Front Microbiol. 2018 May 15;9:975. doi: 10.3389/fmicb.2018.00975. eCollection 2018.

4.

S100A7: from mechanism to cancer therapy.

Padilla L, Dakhel S, Adan J, Masa M, Martinez JM, Roque L, Coll T, Hervas R, Calvis C, Llinas L, Buenestado S, Castellsague J, Messeguer R, Mitjans F, Hernandez JL.

Oncogene. 2017 Dec 7;36(49):6749-6761. doi: 10.1038/onc.2017.283. Epub 2017 Aug 21.

PMID:
28825725
5.

Late complications of percutaneous tracheostomy using the balloon dilation technique.

Araujo JB, Añón JM, García de Lorenzo A, García-Fernandez AM, Esparcia M, Adán J, Relanzon S, Quiles D, de Paz V, Molina A.

Med Intensiva. 2018 Apr;42(3):151-158. doi: 10.1016/j.medin.2017.05.005. Epub 2017 Jun 23. English, Spanish.

6.

RCAN 1 and 3 proteins regulate thymic positive selection.

Serrano-Candelas E, Alemán-Muench G, Solé-Sánchez S, Aubareda A, Martínez-Høyer S, Adán J, Aranguren-Ibáñez Á, Pritchard MA, Soldevila G, Pérez-Riba M.

Biochem Biophys Res Commun. 2015 May 1;460(2):295-301. doi: 10.1016/j.bbrc.2015.03.029. Epub 2015 Mar 14.

PMID:
25783055
7.

In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles.

Baldi G, Ravagli C, Mazzantini F, Loudos G, Adan J, Masa M, Psimadas D, Fragogeorgi EA, Locatelli E, Innocenti C, Sangregorio C, Comes Franchini M.

Int J Nanomedicine. 2014 Jun 24;9:3037-56. doi: 10.2147/IJN.S61273. eCollection 2014.

8.

S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer.

Dakhel S, Padilla L, Adan J, Masa M, Martinez JM, Roque L, Coll T, Hervas R, Calvis C, Messeguer R, Mitjans F, Hernández JL.

Oncogenesis. 2014 Mar 17;3:e92. doi: 10.1038/oncsis.2014.7.

9.

Tackling lipophilicity of peptide drugs: replacement of the backbone N-methyl group of cilengitide by N-oligoethylene glycol (N-OEG) chains.

Fernández-Llamazares AI, Adan J, Mitjans F, Spengler J, Albericio F.

Bioconjug Chem. 2014 Jan 15;25(1):11-7. doi: 10.1021/bc4003844. Epub 2013 Dec 17.

PMID:
24328341
10.

Micropattern of antibodies imaged by shear force microscopy: comparison between classical and jumping modes.

González L, Otero J, Agusil JP, Samitier J, Adan J, Mitjans F, Puig-Vidal M.

Ultramicroscopy. 2014 Jan;136:176-84. doi: 10.1016/j.ultramic.2013.09.008. Epub 2013 Oct 17.

PMID:
24184681
11.

Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody.

Hernández JL, Padilla L, Dakhel S, Coll T, Hervas R, Adan J, Masa M, Mitjans F, Martinez JM, Coma S, Rodríguez L, Noé V, Ciudad CJ, Blasco F, Messeguer R.

PLoS One. 2013 Sep 4;8(9):e72480. doi: 10.1371/journal.pone.0072480. eCollection 2013.

12.

The backbone N-(4-azidobutyl) linker for the preparation of peptide chimera.

Fernández-Llamazares AI, García J, Adan J, Meunier D, Mitjans F, Spengler J, Albericio F.

Org Lett. 2013 Sep 6;15(17):4572-5. doi: 10.1021/ol402150m. Epub 2013 Aug 22.

PMID:
24006938
13.

Dual effects of β3 integrin subunit expression on human pancreatic cancer models.

Marchán S, Pérez-Torras S, Vidal A, Adan J, Mitjans F, Carbó N, Mazo A.

Cell Oncol (Dordr). 2011 Aug;34(4):393-405. doi: 10.1007/s13402-011-0039-3. Epub 2011 May 31.

PMID:
21626402
14.

Dual effects of β3 integrin subunit expression on human pancreatic cancer models.

Marchán S, Pérez-Torras S, Vidal A, Adan J, Mitjans F, Carbó N, Mazo A.

Anal Cell Pathol (Amst). 2010;33(5):191-205. doi: 10.3233/ACP-CLO-2010-0538. Erratum in: Cell Oncol (Dordr). 2011 Aug;34(4):407-8.

15.

Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.

Mencía N, Selga E, Rico I, de Almagro MC, Villalobos X, Ramirez S, Adan J, Hernández JL, Noé V, Ciudad CJ.

BMC Cancer. 2010 Jun 1;10:250. doi: 10.1186/1471-2407-10-250.

16.

Amide-to-ester substitution allows fine-tuning of the cyclopeptide conformational ensemble.

Cupido T, Spengler J, Ruiz-Rodriguez J, Adan J, Mitjans F, Piulats J, Albericio F.

Angew Chem Int Ed Engl. 2010 Apr 1;49(15):2732-7. doi: 10.1002/anie.200907274. No abstract available.

PMID:
20213784
17.

[Applicability of the ICF in measuring functioning and disability in unipolar depression in Primary Care settings].

Nieto-Moreno M, Gimeno Blanco P, Adán J, García-Olmos L, Valle J, Chatterji S, Leonardi M, Ayuso-Mateos J; Grupo de Investigación ITACM.

Actas Esp Psiquiatr. 2006 Nov-Dec;34(6):393-6. Spanish.

PMID:
17117336
18.

Anti-migratory and anti-angiogenic effect of p16: a novel localization at membrane ruffles and lamellipodia in endothelial cells.

Alhaja E, Adan J, Pagan R, Mitjans F, Cascalló M, Rodríguez M, Noé V, Ciudad CJ, Mazo A, Vilaró S, Piulats J.

Angiogenesis. 2004;7(4):323-33. Epub 2005 May 9.

PMID:
15886876
19.

[Vagus nerve stimulation and psychosis. A single case report].

Adán J, Escosa M, Ayuso-Mateos JL.

Actas Esp Psiquiatr. 2005 Mar-Apr;33(2):130-4. Spanish.

PMID:
15768321
20.

Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.

Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J, Ciudad CJ.

Oligonucleotides. 2004;14(2):100-13.

PMID:
15294074
21.

Serum amino acid levels after permanent middle cerebral artery occlusion in the rat.

Puig N, Dávalos A, Adan J, Piulats J, Martínez JM, Castillo J.

Cerebrovasc Dis. 2000 Nov-Dec;10(6):449-54.

PMID:
11070375
22.

Pharmacokinetics of oligodeoxynucleotides encapsulated in liposomes: effect of lipid composition and preparation method.

Aliño SF, Crespo J, Tarrasón G, Blaya C, Adán J, Escrig E, Benet M, Crespo A, Peris JE, Piulats J.

Xenobiotica. 1999 Dec;29(12):1283-91.

PMID:
10647913
23.

In vitro and in vivo protective effect of orphenadrine on glutamate neurotoxicity.

Sureda FX, Gabriel C, Pallàs M, Adan J, Martínez JM, Escubedo E, Camarasa J, Camins A.

Neuropharmacology. 1999 May;38(5):671-7.

PMID:
10340304
24.

Effects of NMDA-R1 antisense oligodeoxynucleotide administration: behavioral and radioligand binding studies.

Zapata A, Capdevila JL, Tarrason G, Adan J, Martínez JM, Piulats J, Trullas R.

Brain Res. 1997 Jan 16;745(1-2):114-20.

PMID:
9037399
25.

An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice.

Mitjans F, Sander D, Adán J, Sutter A, Martinez JM, Jäggle CS, Moyano JM, Kreysch HG, Piulats J, Goodman SL.

J Cell Sci. 1995 Aug;108 ( Pt 8):2825-38.

26.

Supplemental Content

Support Center